Core One Labs Prepares First in Series of Patent Applications
VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / Core One Labs Inc. (CSE:COOL)(OTC Pink:CLABF)(Frankfurt:LD62, WKN:A2P8K3) (the "Company" or "Core...
Day: February 10, 2021
Authorized West Virginia Medical Marijuana Dispensary List Has Been Released
FREDERICK, MD / ACCESSWIRE / February 10, 2021 / Green Health Docs, based in Frederick, MD, is happy to announce...
Kadmon Announces Proposed $150 Million Convertible Senior Notes Offering with Capped Call Transactions
NEW YORK, NY / ACCESSWIRE / February 10, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced its intent to offer,...
MassMEDIC Announces Finalists in its MedTech IGNITE Accelerator
Six Startup Founders Will Compete for Cash Prizes at Live Pitch Event on February 24th BOSTON, MA / ACCESSWIRE /...
Foothold Technology Acquires Relevant Health Homes, Adding an Industry Leading Care Management Platform to Its Product Offerings
NEW YORK--(BUSINESS WIRE)--Today, Foothold Technology, a leading cloud-based behavioral health and human services EHR software provider backed by ASG, announced...
Texas Medical Technology Partners With Proguardeum Inc. to Boost Safety and Sustainability in Its Smart Solutions
Armed with the unique Optimum™ solution, Texas Medical Technology will deliver its advanced array of products with an effective, sustainable,...
Huami Corp Invests $5 Million in Hyperfine Research D Round to Support Accelerated Application of Disruptive MRI Technology
BEIJING & CUPERTINO, Calif.--(BUSINESS WIRE)--Huami Corp. (NYSE: HMI) today announced that it has invested $5 million in Hyperfine Research’s D...
Inogen Announces Participation in the 10th Annual SVB Leerink Global Healthcare Conference
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting,...
Vitana-X Getting Ready to Launch a Vitamin Shot Drink
MIAMI, FL / ACCESSWIRE / February 10, 2021 / VitanaX, Inc. (OTC:VITX), a provider of comprehensive programs for greater well-being,...
How Innovative Advancements are Spurring Growth of Reposable Deflectable Catheters Market: Future Market Insights Report Analyzes
Market players are focusing on capacity expansion to attain a competitive edge. DUBAI, UAE / ACCESSWIRE / February 10, 2021...
CareATC Provides the City of Goodyear First Doses of Moderna COVID-19 Vaccine
GOODYEAR, AZ / ACCESSWIRE / February 10, 2021 / The city of Goodyear partnered with workforce health leader, CareATC, to...
Why You Should Choose a Prosthodontist Like Dr. Tareq Burezq Over a General Dentist
LOS ANGELES, CA / ACCESSWIRE / February 10, 2021 / If you are like most people, you will go to...
CTC Diagnostics Manufacturers Proliferating amid Accelerating Cancer Stem Cell Research Initiatives: Fact.MR Study
High potential in discovering possible breakthroughs by supplementing the natural immune system is accelerating research efforts ROCKVILLE, MD / ACCESSWIRE...
Celon Pharma Announces Successful Completion of Phase 1A Trial of CPL’116, JAK-ROCK Inhibitor
KIELPIN, Poland, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Celon Pharma S.A. today announced the successful completion of its Phase 1A...
REPEAT – Pure Extracts Announces Its First Commercial Sale of CBD Oil on the Wholesale Market
VANCOUVER, British Columbia, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
LipoMedix Announces Manufacturing Agreement with ForDoz for Promitil®
JERUSALEM, Israel, Feb. 10, 2021 (GLOBE NEWSWIRE) -- LipoMedix, a clinical-stage, oncology-focused pharmaceutical company involved in the development of innovative,...
AREV Nanotechnology becomes a sponsor of the National Sciences Academy 2021 Hemp Symposium
VANCOUVER, British Columbia, Feb. 10, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV NanoTec”), which...
Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPF
Foster City, CA and Mechelen, Belgium, 10 February 2021, 15.00 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) and...
Infant Bacterial Therapeutics announces that the recruitment to the first stage of the Phase III Connection Study is completed – an update about the clinical development of IBP-9414
Infant Bacterial Therapeutics (IBT) announces that the company has reached an important milestone after recruiting 300 premature infants to the...
Panbela Announces Research Agreement with Johns Hopkins University School of Medicine
MINNEAPOLIS, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics...